Literature DB >> 15654974

A proteolytic cascade of kallikreins in the stratum corneum.

Maria Brattsand1, Kristina Stefansson, Christine Lundh, Ylva Haasum, Torbjörn Egelrud.   

Abstract

Serine proteases belonging to the kallikrein group may play a central role in desquamation. We have identified human kallikreins 5, 7, and 14 (hK5, hK7, hK14) in catalytically active form in stratum corneum. All three enzymes are produced as inactive precursors. In this work, we prepared recombinant enzymes and enzyme precursors and characterized the catalytic properties of hK5 and hK14. With peptide substrates hK5 and hK14 both showed trypsin-like specificity and alkaline pH-optima. For the substrates tested, hK14 was superior to hK5 as regards maximum catalytic rate as well as catalytic efficiency. hK5, but not hK14, could activate pro-hK7 in a reaction which was optimal at pH 5-7. hK5 could activate its own precursor as well as pro-hK14. This was in contrast to hK14, which could activate pro-hK5 but not its own precursor. The activation of pro-hK5 either by auto-activation or by hK14 occurred at maximum rate at neutral or weakly alkaline pH, whereas activation of pro-hK14 by hK5 was optimal at pH 6-7. We conclude that the enzymes studied may be part of a protease cascade in the stratum corneum, and that the observed pH effects may have physiological relevance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654974     DOI: 10.1111/j.0022-202X.2004.23547.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  77 in total

Review 1.  Involvement of corneodesmosome degradation and lamellar granule transportation in the desquamation process.

Authors:  Akemi Ishida-Yamamoto; Mari Kishibe
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

2.  LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.

Authors:  Celine Deraison; Chrystelle Bonnart; Frederic Lopez; Celine Besson; Ross Robinson; Arumugam Jayakumar; Fredrik Wagberg; Maria Brattsand; Jean Pierre Hachem; Goran Leonardsson; Alain Hovnanian
Journal:  Mol Biol Cell       Date:  2007-06-27       Impact factor: 4.138

Review 3.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

Review 4.  Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia.

Authors:  Hermann H Bragulla; Dominique G Homberger
Journal:  J Anat       Date:  2009-04       Impact factor: 2.610

Review 5.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

6.  Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis.

Authors:  Peter M Elias
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 7.  "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

Authors:  Peter M Elias; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2008-05       Impact factor: 8.551

8.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

9.  pH-regulated mechanisms account for pigment-type differences in epidermal barrier function.

Authors:  Roshan Gunathilake; Nanna Y Schurer; Brenda A Shoo; Anna Celli; Jean-Pierre Hachem; Debra Crumrine; Ganga Sirimanna; Kenneth R Feingold; Theodora M Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

10.  The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2009-12-02       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.